Wusheng Lu

Chengdu, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Conversion Resection or Direct Resection for Patients with Intermediate-Stage Hepatocellular Carcinoma: A Multicentre Study.

Conversion Resection or Direct Resection for Patients with Intermediate-Stage Hepatocellular Carcinoma: A Multicentre Study.

Journal: Liver cancer

Published: May 13, 2025

Lenvatinib plus transarterial chemoembolization and PD-1 inhibitors as conversion therapies for unresectable intermediate-advanced hepatocellular carcinoma: a phase 2 trial and exploratory biomolecular study.

Lenvatinib plus transarterial chemoembolization and PD-1 inhibitors as conversion therapies for unresectable intermediate-advanced hepatocellular carcinoma: a phase 2 trial and exploratory biomolecular study.

Journal: Signal transduction and targeted therapy

Published: November 03, 2024

Liver transplantation for advanced hepatocellular carcinoma after downstaging with consequential lenvatinib, transcatheter arterial chemoembolization and camrelizumab.

Liver transplantation for advanced hepatocellular carcinoma after downstaging with consequential lenvatinib, transcatheter arterial chemoembolization and camrelizumab.

Journal: The British journal of surgery

Published: July 25, 2023

Programmed cell death protein 1 and tyrosine kinase inhibition plus transcatheter arterial chemoembolization of advanced hepatocellular carcinoma.

Programmed cell death protein 1 and tyrosine kinase inhibition plus transcatheter arterial chemoembolization of advanced hepatocellular carcinoma.

Journal: The British journal of surgery

Published: August 17, 2022

Conversion resection for patients with hepatocellular carcinoma and inferior vena cava tumor thrombus: a consecutive case series.

Conversion resection for patients with hepatocellular carcinoma and inferior vena cava tumor thrombus: a consecutive case series.

Journal: Chinese medical journal

Published: July 21, 2022

131Iodine-DEM TACE vs. conventional TACE in cirrhotic patients with hepatocellular carcinoma: a single center experiment.

131Iodine-DEM TACE vs. conventional TACE in cirrhotic patients with hepatocellular carcinoma: a single center experiment.

Journal: Journal of gastrointestinal oncology

Published: May 20, 2021

Changes of alpha-fetoprotein levels could predict recurrent hepatocellular carcinoma survival after trans-arterial chemoembolization.

Changes of alpha-fetoprotein levels could predict recurrent hepatocellular carcinoma survival after trans-arterial chemoembolization.

Journal: Oncotarget

Published: February 27, 2017

Combating Superbug Without Antibiotic on a Postamputation Wound in a Patient with Diabetic Foot.

Combating Superbug Without Antibiotic on a Postamputation Wound in a Patient with Diabetic Foot.

Journal: The international journal of lower extremity wounds

Published: August 05, 2015

Appropriate treatment strategies for intrahepatic recurrence after curative resection of hepatocellular carcinoma initially within the Milan criteria: according to the recurrence pattern.

Appropriate treatment strategies for intrahepatic recurrence after curative resection of hepatocellular carcinoma initially within the Milan criteria: according to the recurrence pattern.

Journal: European journal of gastroenterology & hepatology

Published: May 02, 2015

Preoperative transarterial chemoembolization does not increase hepatic artery complications after liver transplantation: A single center 12-year experience.

Preoperative transarterial chemoembolization does not increase hepatic artery complications after liver transplantation: A single center 12-year experience.

Journal: Clinics and research in hepatology and gastroenterology

Published: September 24, 2014

Showing 1-10 of 10

Last Updated: 09/26/2026